Tvardi Therapeutics, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To elect the Board of Directors' three nominees, Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah, for Class Il director to serve until the 2029 Annual Meeting of Stockholders: Cynthia Smith

Tvardi Therapeutics, Inc.’s own tally for this item (“Elect Director: Cynthia Smith”): 3,392,877 for, 267,634 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah were each elected to serve as a Class II director of the Company's Board of Directors until the 2029 Annual Meeting of Stockholders and until their successor is duly elected or until their earlier resignation or r…”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 683,419 for, 5,527 withheld.

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

Description as filed by funds: To elect the Board of Directors' three nominees, Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah, for Class Il director to serve until the 2029 Annual Meeting of Stockholders: Imran Alibhai, Ph.D.

Tvardi Therapeutics, Inc.’s own tally for this item (“Elect Director: Imran Alibhai, Ph.D.”): 3,513,039 for, 147,472 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 688,946 for.

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

Description as filed by funds: To elect the Board of Directors' three nominees, Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah, for Class Il director to serve until the 2029 Annual Meeting of Stockholders: Sujal Shah

Tvardi Therapeutics, Inc.’s own tally for this item (“Elect Director: Sujal Shah”): 3,507,652 for, 152,859 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah were each elected to serve as a Class II director of the Company's Board of Directors until the 2029 Annual Meeting of Stockholders and until their successor is duly elected or until their earlier resignation or r…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 687,797 for, 1,149 withheld.

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.

Tvardi Therapeutics, Inc.’s own tally for this item (“2. Non-Binding, Advisory Vote on Executive Compensation”): 3,482,265 for, 161,795 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Non-Binding, Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, by the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 26 managers: 688,936 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports, all 79 managers: 1,410,193 for, 5,898 against, 905 1 year. Showing the 25 largest; every one is in the interactive database (link above).

Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 26 managers: 688,924 1 year, 12 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports, all 79 managers: 915 for, 1,416,049 1 year, 32 3 year. Showing the 25 largest; every one is in the interactive database (link above).

Description as filed by funds: TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026.

Tvardi Therapeutics, Inc.’s own tally for this item (“4. Ratification of the Selection of Independent Registered Public Accounting Firm”): 6,523,292 for, 62,646 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - Ratification of the Selection of Independent Registered Public Accounting Firm The stockholders ratified the selection by the Audit Committee of the Board of Directors of the Company of Deloitte & Touche LLP as the Company's independent registered public accounting firm for its fiscal …”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 27 asset managers below reported 688,946 for.

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).